315 Gala: Exposing the Miracle Cure for Fake Drugs

In recent years, extracellular vesicles have been very popular in the anti-aging field. This is a type of product that has been hot on the medical beauty market recently. According to introductions from various medical publications and industry insiders, the magical substance "extracellular vesicles" promoted by anchors is actually a bioactive substance secreted during the cultivation of stem cells. However, the role and mechanism of this substance in the medical and academic fields, as well as clinical testing and other medical procedures, are not yet clear, and most of the research is still in the academic and theoretical research stage. According to a query by a reporter, in June 2025, the National Medical Products Administration Drug Evaluation Center issued a draft for soliciting opinions, proposing to regulate extracellular vesicles with therapeutic functions and actions based on active ingredients as drugs. However, this is just a draft for soliciting opinions. The goal is to control the entry of such substances into society to prevent abuse or misuse. As of now, no extracellular vesicle drugs have been approved for marketing in China. In order to understand the specific situation, a reporter from the 315 Evening News, based on information provided by consumers, found a product called "Qingcheng" on the market. Personnel from the manufacturer, Haolin Biotechnology Co., Ltd., told the reporter that their product is mainly composed of extracellular vesicles. However, in order to evade market supervision, they used a collagen license. False production, illegal additives, and illegal sales are not the full extent of the chaos of extracellular vesicles in the market. Some companies also engage in false advertising, claiming that their "extracellular vesicle" products not only have cosmetic anti-aging effects, but can even treat various diseases! In a certain city in Southwest China, the head of Jiebosai'er Biotechnology Co., Ltd. openly told the reporter that they are using extracellular vesicles to treat diseases. According to him, diseases such as epilepsy, arthritis, and diabetes can be treated by using extracellular vesicles. Seeing the reporter's disbelief, the head directly took out the so-called medical-grade extracellular vesicle frozen solution from the refrigerator to show the reporter. The packaging of the product had no product information, fitting the criteria of a "three-no" product. The head also told the reporter that since their company does not have medical qualifications, the injection of extracellular vesicles can only be done in cooperation with medical institutions, a practice known in the industry as "borrowing the platform to hit the ball." In this way, these companies have packaged the so-called "extracellular vesicles," which have not been approved by the government, have not undergone any clinical trials, and have no efficacy data, as a "cure-all" "miracle drug." They have even injected them into patients' bodies in a "borrowing the platform to hit the ball" manner, and this business can be quite profitable. The head explained, "The first time costs 15 billion, the second time 20 billion, the third time 25 billion. Gradually it adds up to a total of 60 billion, charging 60,000 yuan."